Diarylheptanoids suppress proliferation of pancreatic cancer PANC-1 cells through modulating shh-Gli-FoxM1 pathway. 2017

Guang-Zhi Dong, and Ji Hye Jeong, and Yu-Ih Lee, and So Yoon Lee, and Hui-Yuan Zhao, and Raok Jeon, and Hwa Jin Lee, and Jae-Ha Ryu
Research Center for Cell Fate Control and College of Pharmacy, Sookmyung Women's University, 52 Hyochanwon-Gil, Yongsan-Gu, Seoul, 140-742, Republic of Korea.

Pancreatic cancer is one of the leading causes of cancer, and it has the lowest 5-year survival rates. It is necessary to develop more potent anti-pancreatic cancer drugs to overcome the fast metastasis and resistance to surgery, radiotherapy, chemotherapy, and combinations of these. We have identified several diarylheptanoids as anti-pancreatic cancer agents from Alpinia officinarum (lesser galangal) and Alnus japonica. These diarylheptanoids suppressed cell proliferation and induced the cell cycle arrest of pancreatic cancer cells (PANC-1). Among them, the most potent compounds 1 and 7 inhibited the shh-Gli-FoxM1 pathway and their target gene expression in PANC-1 cells. Furthermore, they suppressed the expression of the cell cycle associated genes that were rescued by the overexpression of exogenous FoxM1. Taken together, (E)-7-(4-hydroxy-3-methoxyphenyl)-1-phenylhept-4-en-3-one (1) from Alpinia officinarum (lesser galangal) and platyphyllenone (7) from Alnus japonica inhibit PANC-1 cell proliferation by suppressing the shh-Gli-FoxM1 pathway, and they can be potential candidates for anti-pancreatic cancer drug development.

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071676 Zinc Finger Protein GLI1 A transcriptional activator and oncogene protein that contains two CYS2-HIS2 ZINC FINGERS. Two isoforms are expressed; both regulate the expression of specific genes during development of craniofacial features, digits, the CENTRAL NERVOUS SYSTEM; and the GASTROINTESTINAL TRACT. They also regulate SONIC HEDGEHOG PROTEIN signaling and cell proliferation. Gli Protein,Gli1 Protein,Glioma-Associated Oncogene Protein,Oncogene GLI Protein,GLI Protein, Oncogene,Glioma Associated Oncogene Protein,Oncogene Protein, Glioma-Associated
D000072278 Forkhead Box Protein M1 A forkhead box transcription factor that is expressed primarily in adult organs which contain proliferating cells such as the thymus, testis, ovary, and small intestine. It controls the expression of CELL CYCLE genes essential for DNA REPLICATION and MITOSIS, and also functions in DNA REPAIR. FOXM1 Protein
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Guang-Zhi Dong, and Ji Hye Jeong, and Yu-Ih Lee, and So Yoon Lee, and Hui-Yuan Zhao, and Raok Jeon, and Hwa Jin Lee, and Jae-Ha Ryu
May 2021, Molecules (Basel, Switzerland),
Guang-Zhi Dong, and Ji Hye Jeong, and Yu-Ih Lee, and So Yoon Lee, and Hui-Yuan Zhao, and Raok Jeon, and Hwa Jin Lee, and Jae-Ha Ryu
December 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Guang-Zhi Dong, and Ji Hye Jeong, and Yu-Ih Lee, and So Yoon Lee, and Hui-Yuan Zhao, and Raok Jeon, and Hwa Jin Lee, and Jae-Ha Ryu
April 2019, Journal of cellular and molecular medicine,
Guang-Zhi Dong, and Ji Hye Jeong, and Yu-Ih Lee, and So Yoon Lee, and Hui-Yuan Zhao, and Raok Jeon, and Hwa Jin Lee, and Jae-Ha Ryu
June 2018, International journal of oncology,
Guang-Zhi Dong, and Ji Hye Jeong, and Yu-Ih Lee, and So Yoon Lee, and Hui-Yuan Zhao, and Raok Jeon, and Hwa Jin Lee, and Jae-Ha Ryu
October 2016, Journal of cancer research and therapeutics,
Guang-Zhi Dong, and Ji Hye Jeong, and Yu-Ih Lee, and So Yoon Lee, and Hui-Yuan Zhao, and Raok Jeon, and Hwa Jin Lee, and Jae-Ha Ryu
November 2017, Anticancer research,
Guang-Zhi Dong, and Ji Hye Jeong, and Yu-Ih Lee, and So Yoon Lee, and Hui-Yuan Zhao, and Raok Jeon, and Hwa Jin Lee, and Jae-Ha Ryu
May 2020, Journal of Asian natural products research,
Guang-Zhi Dong, and Ji Hye Jeong, and Yu-Ih Lee, and So Yoon Lee, and Hui-Yuan Zhao, and Raok Jeon, and Hwa Jin Lee, and Jae-Ha Ryu
January 2007, Anticancer research,
Guang-Zhi Dong, and Ji Hye Jeong, and Yu-Ih Lee, and So Yoon Lee, and Hui-Yuan Zhao, and Raok Jeon, and Hwa Jin Lee, and Jae-Ha Ryu
April 2018, Journal of proteome research,
Guang-Zhi Dong, and Ji Hye Jeong, and Yu-Ih Lee, and So Yoon Lee, and Hui-Yuan Zhao, and Raok Jeon, and Hwa Jin Lee, and Jae-Ha Ryu
June 2020, Journal of molecular cell biology,
Copied contents to your clipboard!